| 000 | 01797 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516191902.0 | ||
| 264 | 0 | _c20140430 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1945-7170 | ||
| 024 | 7 |
_a10.1210/en.2013-1781 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aForest, Thomas | |
| 245 | 0 | 0 |
_aCharacterization of the exocrine pancreas in the male Zucker diabetic fatty rat model of type 2 diabetes mellitus following 3 months of treatment with sitagliptin. _h[electronic resource] |
| 260 |
_bEndocrinology _cMar 2014 |
||
| 300 |
_a783-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKeratins _xmetabolism |
| 650 | 0 | 4 |
_aKi-67 Antigen _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xadministration & dosage |
| 650 | 0 | 4 |
_aPancreas, Exocrine _xdrug effects |
| 650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Zucker |
| 650 | 0 | 4 | _aSitagliptin Phosphate |
| 650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
| 700 | 1 | _aHolder, Daniel | |
| 700 | 1 | _aSmith, Adam | |
| 700 | 1 | _aCunningham, Caron | |
| 700 | 1 | _aYao, Xiaorui | |
| 700 | 1 | _aDey, Markus | |
| 700 | 1 | _aFrederick, Clay | |
| 700 | 1 | _aPrahalada, Srinivasa | |
| 773 | 0 |
_tEndocrinology _gvol. 155 _gno. 3 _gp. 783-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2013-1781 _zAvailable from publisher's website |
| 999 |
_c23448619 _d23448619 |
||